CARsgen Therapeutics Holdings Limited (02171) disclosed updates on its ordinary shares, including a repurchase on 11 November 2025. The closing balance that day reached 575,086,905 issued shares (excluding treasury shares) and 2,855,500 treasury shares, maintaining a total of 577,942,405 issued shares.

The repurchase on 11 November 2025 involved 245,000 shares at HKD16.5193 per share. A revised disclosure confirmed that the aggregate repurchase price amounted to HKD4,047,240. Shares repurchased on 21 and 23 October 2025 for cancellation, totaling 455,000 shares, remained pending cancellation as of the closing balance date.